BT-GSI Catalog No.:M33705-C shows a sustained antagonist action

shows a sustained antagonist action without evidence of agonist effects

Chemical Name: 2-{4-[4-(tert-butylcarbamoyl)-2-(2-chloro-4-cyclopropylbenzenesulfonamido)phenoxy]-5-chloro-2-fluorophenyl}acetic acid

MC4R and MC5R

and OPA-15406 also exerts inhibitory effects on PDE2

or the amino-termini of polypeptides

BT-GSI Catalog No.:M33705-C shows a sustained antagonist actionBT GSI is a secretase inhibitor (GSI) and a bone targeted Notch inhibitor. BT GSI has dual anti myeloma and anti resorptive properties, which can be used for the research of multiple myeloma and associated bone disease. BT GSI inhibits tumor growth and osteolytic disease progression. Product information Molecular Weight: 730. 52 Formula: C26H46BrN5O10P2 Smiles: Br. CC(C)C[C@@H]( C=N